Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI
Filiz Izci1, Merve Iris Koc2, Rabia Bilici2
1Department of Psychiatry, School of Medicine, Istanbul Bilim University, Abide-i Hurriyet Caddesi No. 164, Sisli, Istanbul, Turkey.
Abstract:
Bupropion hydrochloride (HCI) is an antidepressant that acts as a norepinephrine and dopamine reuptake inhibitor and has three different dosage forms including immediate release (IR), sustained release (SR), and extended release (ER). Despite its relatively safe side effect profile bupropion may cause several side effects. Here, we aimed to report a case with major depression using extended release form of bupropion hydrochloride who was presented with urinary incontinence during sleep, an uncommon side effect of bupropion.
Related Concept Videos
Oral Drug Delivery Systems: Continuous-Release Systems
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Management of Insomnia
CNS Depressants: Barbiturates and Benzodiazepines


